Validation of the Effectiveness of anti-herpesvirus Inhibitors for EEHV Disease

Only ten out of 70 elephants with confirmed EEHV disease have survived, all after medication treatments that include one of two drugs known to target the lytic replication of certain human herpesviruses. The rationale that either drug works against EEHV is purely theoretical and at least twice as many calves that have also been treated similarly did not survive. This project carried out sophisticated basic research experiments designed to answer which if any of these two drugs were indeed truly capable of stopping EEHV.

IEF #EX1018

Project Years: 2012 – 2013

Project Partners:
Dr. Gary Hayward, Johns Hopkins University